u/ferran_krastev

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

Half-life is about 168 hours, so steady state lands around week 4–5. Practical consequence: what you feel in week 1 is not what that dose does.

the regain is treatment of chronic condition ending, not failure

integration decision on a shoulder changes your number by half a point on its own

the gradient is doing the separation work, not the column alone

early fullness at 0.25mg is different from 15mg

My sulphur burps was worst at 10mg and better at 7.5mg, which makes no sense but it is real.

My constipation was worst at 2.4mg and better at 0.5mg, which makes no sense but it is real.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

coming off deliberately, not by accident

two labs, two different baselines, two different purity numbers, both honest

Strongly agree. Largest single impurity tells a different story than total purity.

say how long you were on and at what dose before taper

Adding to this: tapering is doing more work than the comment implies.

FFMI tracking requires body composition

Strongly agree.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Small correction: the trial was 5 weeks, not 34. Does not change your point but people will quote it.

Small correction: the trial was 17 weeks, not 4. Does not change your point but people will quote it.

Same experience. Week 61 and it simply stopped. I know that is not useful information but it is what happened.

heart rate and dose escalation need actual measurements, not impressions

I am going to push back on this slightly.